Literature DB >> 32041276

A Review of Small Molecule Inhibitors and Functional Probes of Human Cathepsin L.

Dibyendu Dana1, Sanjai K Pathak1,2.   

Abstract

Human cathepsin L belongs to the cathepsin family of proteolytic enzymes with primarily an endopeptidase activity. Although its primary functions were originally thought to be only of a housekeeping enzyme that degraded intracellular and endocytosed proteins in lysosome, numerous recent studies suggest that it plays many critical and specific roles in diverse cellular settings. Not surprisingly, the dysregulated function of cathepsin L has manifested itself in several human diseases, making it an attractive target for drug development. Unfortunately, several redundant and isoform-specific functions have recently emerged, adding complexities to the drug discovery process. To address this, a series of chemical biology tools have been developed that helped define cathepsin L biology with exquisite precision in specific cellular contexts. This review elaborates on the recently developed small molecule inhibitors and probes of human cathepsin L, outlining their mechanisms of action, and describing their potential utilities in dissecting unknown function.

Entities:  

Keywords:  CA-074; E-64; KDP-1; activity-based probes; cathepsin L ABP; cathepsin L inhibitor; cathepsin L probe; clickable ABP; human cathepsin L

Year:  2020        PMID: 32041276     DOI: 10.3390/molecules25030698

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  21 in total

1.  A humanized antibody inhibitor for cathepsin L.

Authors:  Xiaojing Shi; Yong Zhang
Journal:  Protein Sci       Date:  2020-08-07       Impact factor: 6.725

Review 2.  An insight into SARS-CoV-2 structure, pathogenesis, target hunting for drug development and vaccine initiatives.

Authors:  Arijit Ghosh; Paritosh K Kar; Anupam Gautam; Rahul Gupta; Rajveer Singh; Rudra Chakravarti; Velayutham Ravichandiran; Shubhra Ghosh Dastidar; Dipanjan Ghosh; Syamal Roy
Journal:  RSC Med Chem       Date:  2022-01-25

3.  Dual-Mechanism Quenched Fluorogenic Probe Provides Selective and Rapid Detection of Cathepsin L Activity*.

Authors:  Kelton A Schleyer; Ben Fetrow; Peter Zannes Fatland; Jun Liu; Maya Chaaban; Biwu Ma; Lina Cui
Journal:  ChemMedChem       Date:  2021-01-15       Impact factor: 3.466

Review 4.  Cathepsins in the Pathophysiology of Mucopolysaccharidoses: New Perspectives for Therapy.

Authors:  Valeria De Pasquale; Anna Moles; Luigi Michele Pavone
Journal:  Cells       Date:  2020-04-15       Impact factor: 6.600

Review 5.  Coumarin as a structural component of substrates and probes for serine and cysteine proteases.

Authors:  Julian Breidenbach; Ulrike Bartz; Michael Gütschow
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2020-05-13       Impact factor: 3.036

Review 6.  COVID-19/SARS-CoV-2 Infection: Lysosomes and Lysosomotropism Implicate New Treatment Strategies and Personal Risks.

Authors:  Markus Blaess; Lars Kaiser; Martin Sauer; René Csuk; Hans-Peter Deigner
Journal:  Int J Mol Sci       Date:  2020-07-13       Impact factor: 5.923

7.  Structure and inhibition of the SARS-CoV-2 main protease reveals strategy for developing dual inhibitors against Mpro and cathepsin L.

Authors:  Michael Dominic Sacco; Chunlong Ma; Panagiotis Lagarias; Ang Gao; Julia Alma Townsend; Xiangzhi Meng; Peter Dube; Xiujun Zhang; Yanmei Hu; Naoya Kitamura; Brett Hurst; Bart Tarbet; Michael Thomas Marty; Antonios Kolocouris; Yan Xiang; Yu Chen; Jun Wang
Journal:  bioRxiv       Date:  2020-07-27

Review 8.  SARS-CoV-2 Entry Inhibitors: Small Molecules and Peptides Targeting Virus or Host Cells.

Authors:  Rolando Cannalire; Irina Stefanelli; Carmen Cerchia; Andrea R Beccari; Sveva Pelliccia; Vincenzo Summa
Journal:  Int J Mol Sci       Date:  2020-08-09       Impact factor: 5.923

9.  Potential clinical drugs as covalent inhibitors of the priming proteases of the spike protein of SARS-CoV-2.

Authors:  Qizhang Li; Zhiying Wang; Qiang Zheng; Sen Liu
Journal:  Comput Struct Biotechnol J       Date:  2020-08-26       Impact factor: 7.271

Review 10.  The recent outbreaks of human coronaviruses: A medicinal chemistry perspective.

Authors:  Thanigaimalai Pillaiyar; Lukas L Wendt; Manoj Manickam; Maheswaran Easwaran
Journal:  Med Res Rev       Date:  2020-08-27       Impact factor: 12.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.